{"title":"撤回:ALK重排非小细胞肺癌患者表现不佳和弥散性血管内凝血对alectinib的快速和显著反应","authors":"T. Yoshida, T. Hida, Y. Yatabe","doi":"10.1016/J.CTRC.2015.09.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":90461,"journal":{"name":"Cancer treatment communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/J.CTRC.2015.09.008","citationCount":"0","resultStr":"{\"title\":\"WITHDRAWN: Rapid and dramatic response to alectinib in an ALK rearranged NSCLC patient with poor performance status and disseminated intravascular coagulation\",\"authors\":\"T. Yoshida, T. Hida, Y. Yatabe\",\"doi\":\"10.1016/J.CTRC.2015.09.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":90461,\"journal\":{\"name\":\"Cancer treatment communications\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/J.CTRC.2015.09.008\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer treatment communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/J.CTRC.2015.09.008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.CTRC.2015.09.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
WITHDRAWN: Rapid and dramatic response to alectinib in an ALK rearranged NSCLC patient with poor performance status and disseminated intravascular coagulation